摘要
目的:通过观察他克莫司(tacrolimus,FK506)对2型糖尿病大鼠(T2DM)肾脏中血管生成素样蛋白2(ANGPTL2)表达的影响,探讨其对肾脏的保护机制。方法:50只SD雄性大鼠随机分为正常对照组(NC,10只)和实验组(40只),实验组予高糖高脂喂养联合小剂量链脲佐菌素(STZ 30 mg/kg),建立T2DM大鼠模型。成功模型(32只)再随机分为两组:糖尿病对照组(DM,16只)及他克莫司组(DT,16只)。他克莫司干预8周后,测体重、血压、肾重、血糖、血肌酐(Scr)、尿素氮(BUN)、24 h尿蛋白(UAL)的排泄量;镜下观察肾组织病理改变、免疫组化染色技术、实时定量PCR及Western blot法检测肾组织ANGPTL2、Nephrin、Podocin mRNA及蛋白表达的变化。结果:DM组24 h UAL排泄量及足细胞损伤明显高于NC组,同时ANGPTL2 mRNA及蛋白表达量明显升高(P均<0.05),Nephrin及Podocin的mRNA及蛋白表达量明显降低(P<0.05),DT组较DM组24 h UAL排泄量降低,足细胞损伤改善,ANGPTL2 mRNA及蛋白表达量降低(P<0.01),Nephrin及Podocin的mRNA及蛋白表达量升高(P<0.01),且ANGPTL2 mRNA及蛋白表达量与尿白蛋白呈正相关,其与Nephrin及Podocin的mRNA及蛋白表达量呈负相关(P均<0.01)。结论:他克莫司可通过下调ANGPTL2在肾脏的表达,保护足细胞。
Objective: To observe the effect of TacroIimus on the expression of Angiopoietin - like protein 2 ( ANGPTL2 ) in the kidney of diabetic rats and discuss its mechanism. Methods :50 SD male rats were divided into normal control group ( NC, n = 10) and experimental group (n = 40) randomly. The experimental group was fed with high sugar -fat diet and given a low dose streptozocin (STZ 30 mg/kg) established type 2 diabetic model rats, and then the successful induced models randomly divided into 2 groups: diabetes control group (DM) and tacrolimus group (DT). Weight, blood, pressure, blood, glucose, serum creatinine (Scr) , blood iJrea nitrogen (BUN) 24 hour urinary albumin (UAL) and renal histomorphology were observed after Drug intervention for 8 weeks, the expression of ANGPTL2 ,Nephrin and Podocin in renal tissue were detected by immunohistochemisty, real - time PCR and Western blot. Results: UAL in DM group were obviously higher , compare to the NC group ( P 〈 0.05 ), and the mRNA and pro- tein of ANGPTL2 distantly was upregulated compared with NC group (P 〈 0.05 ), the mRNA and protein of Nephrin and Podocin were significantly decreased (P 〈 0.01 ) ; Meanwhile UAL was significantly lower (P 〈 0.01 ). Compared with DM group, and the mRNA and protein of ANGPTL2 downregulated (P 〈 0.01 ). Neverthless, the mRNA and protein of Nephrin and Podocin were significantly upregulated. Conclusion:These results indicate that Tacrolimus could protects the diabetic kidney through decreasing the expression of ANGPTL2.
出处
《中国中西医结合肾病杂志》
2016年第9期766-769,I0001,I0002,共6页
Chinese Journal of Integrated Traditional and Western Nephrology
基金
青岛市科技局基金资助项目(No.2012-1-3-1-(19)-nsh)
关键词
血管生成素样蛋白2
他克莫司
糖尿病肾病
Angiopoietin - like protein 2 (ANGPTL2) Tacrolimus Diabetic kidney disease